Overview

Efficacy of Combination of Biodentine and Simvastatin as a Pulp Capping Materials in Vital Pulpotomy of Primary Molars

Status:
Completed

Trial end date:
2022-07-25

Target enrollment:
0

Participant gender:
All

Summary

Objective: This study was conducted to evaluate the efficacy of combination of biodentine with simvastatin as a pulpotomy agent for vital primary molars clinically and radiographically. Study design: 60 primary molars in 20 children aged 4-7 years old were randomly allocated to three groups, Biodentine, Simvastatin and combination of Biodentine and simvastatin. Clinical and radiographic examinations were conducted at 1, 3, 6, 9 and 12 months after treatment. Key words: Pulpotomy, Primary teeth, Biodentine, Simvastatin.

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Suez Canal University

Treatments:

Simvastatin

Criteria

Inclusion Criteria:

- Apparently healthy children free from any known systemic diseases.

- Parent willing to participate in the study and signed an informed consent.

- Patient had at least three restorable primary molars with a caries- exposed vital pulp

Exclusion Criteria:

- history of spontaneous pain or provoked pain.

- clinical signs and ̸ or symptoms suggesting a non-vital tooth such as (fistula, sinus
tract, soft tissue swelling, mobility or tenderness to percussion).

- non-Restorable tooth

- pathologic or physiologic mobility